194 related articles for article (PubMed ID: 3275438)
1. Impact of molecular genetics on clinical neurology.
Rowland LP
Adv Neurol; 1988; 48():1-15. PubMed ID: 3275438
[No Abstract] [Full Text] [Related]
2. The molecular genetics of neurological disease. Recent advances.
Rosenberg RN
Neurologia; 1993 May; 8(5):116-23. PubMed ID: 8507504
[No Abstract] [Full Text] [Related]
3. The first decade of molecular genetics in neurology: changing clinical thought and practice.
Rowland LP
Ann Neurol; 1992 Aug; 32(2):207-14. PubMed ID: 1510360
[TBL] [Abstract][Full Text] [Related]
4. [Impact of molecular genetics to clinical neurology].
Tsuji S
Seishin Shinkeigaku Zasshi; 1996; 98(9):622-8. PubMed ID: 9064693
[No Abstract] [Full Text] [Related]
5. Molecular genetics, recombinant DNA techniques, and genetic neurological disease.
Rosenberg RN
Ann Neurol; 1984 Jun; 15(6):511-20. PubMed ID: 6378063
[TBL] [Abstract][Full Text] [Related]
6. Medical genetics and clinical neurology: the common ground.
Bird TD
Prog Med Genet; 1985; 6():1-8. PubMed ID: 3915366
[No Abstract] [Full Text] [Related]
7. Genetic strategies for neuromuscular diseases.
Wood DS
Adv Neurol; 1988; 48():145-51. PubMed ID: 2891253
[No Abstract] [Full Text] [Related]
8. Recombinant DNA strategies in genetic neurological diseases.
Roses AD; Pericak-Vance MA; Yamaoka LH; Stubblefield E; Stajich J; Vance JM; Roses MJ; Carter DB
Muscle Nerve; 1983 Jun; 6(5):339-55. PubMed ID: 6310392
[TBL] [Abstract][Full Text] [Related]
9. [DNA markers, genetic counseling and prenatal diagnosis of hereditary diseases. A study of 3 families with Duchenne's muscular dystrophy].
Schwartz M; Nørby S; Brandt NJ
Ugeskr Laeger; 1985 Jul; 147(30):2382-6. PubMed ID: 3864307
[No Abstract] [Full Text] [Related]
10. Molecular basis of genetic heterogeneity: role of the clinical neurologist.
Rowland LP
J Child Neurol; 1998 Mar; 13(3):122-32. PubMed ID: 9535238
[TBL] [Abstract][Full Text] [Related]
11. [DNA markers, genetic counseling and prenatal diagnosis of hereditary disease. A study of 3 families with Duchenne's muscular dystrophy].
Schwartz M; Nørby S; Brandt NJ
Ugeskr Laeger; 1985 Jun; 147(26):2071-5. PubMed ID: 3863357
[No Abstract] [Full Text] [Related]
12. [Trend in molecular biochemical studies on neurological disorders].
Nakazato M; Ohi T; Matsukura S
Nihon Rinsho; 1989 Jan; 47(1):227-38. PubMed ID: 2566696
[No Abstract] [Full Text] [Related]
13. Two cases of isolated glycerol kinase deficiency with heterogeneous neurological symptoms.
Illsinger S; Marquardt I; Lücke T; Hellerud C; Korenke C; Das AM
Dev Med Child Neurol; 2007 May; 49(5):396-7. PubMed ID: 17489818
[No Abstract] [Full Text] [Related]
14. [Glycerol kinase deficiency with dystrophinopathy].
Nakamura A; Takeda S
Ryoikibetsu Shokogun Shirizu; 2001; (35):28-30. PubMed ID: 11555931
[No Abstract] [Full Text] [Related]
15. [Updates in muscular dystrophies].
Erazo-Torricelli R
Rev Neurol; 2004 Nov 1-15; 39(9):860-71. PubMed ID: 15543503
[TBL] [Abstract][Full Text] [Related]
16. The impact of molecular biology on clinical neurology.
Mak W; Ho SL
Hong Kong Med J; 2001 Mar; 7(1):40-9. PubMed ID: 11406675
[TBL] [Abstract][Full Text] [Related]
17. Clinical neurology.
Booker HE; Dahl DS
Prog Neurol Psychiatry; 1969; 24():153-81. PubMed ID: 4313094
[No Abstract] [Full Text] [Related]
18. Molecular basis of neuromuscular diseases.
Chance PF; Ashizawa T; Hoffman EP; Crawford TO
Phys Med Rehabil Clin N Am; 1998 Feb; 9(1):49-81, vi. PubMed ID: 9894134
[TBL] [Abstract][Full Text] [Related]
19. [Development, problems and results of specialty-specific genetic counseling at the Neurology Clinic of the Karl Marx University].
Bachmann H
Psychiatr Neurol Med Psychol (Leipz); 1987 Nov; 39(11):641-50. PubMed ID: 3441572
[TBL] [Abstract][Full Text] [Related]
20. [Renewed interest in muscular dystrophy].
Eymard B
Rev Prat; 2001 Feb; 51(3):262-9. PubMed ID: 11265422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
